Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 20, 2017 03:02 ET | Source: Pulmocide Limited

Pulmocide Limited: Pulmocide Raises $30 Million in Series B Financing

Pulmocide Raises $30 Million in Series B Financing Funding to progress novel wholly-owned compounds for RSV and pulmonary Aspergillosis London, UK, 20 March 2017: Pulmocide Ltd, the UK-based...